Column | I’m an oncologist. Every man should know this about prostate cancer.

Recent coverage across multiple medical and news publications focuses heavily on prostate cancer awareness, screening protocols, and prevention strategies. Healthline reports that cases are currently rising by three percent annually, prompting experts to strongly urge regular screenings. Outlets including KPLC 7 News, the Las Vegas Review-Journal, and triblive.com have published specialized columns and reports directed at men, particularly targeting men over fifty. Local initiatives, such as a Prostate Cancer Awareness Lunch and Learn hosted by the City of Homestead, Florida, are joining institutional efforts led by groups like City of Hope to educate the public on screening, diagnosis, and treatment procedures. Media organizations are emphasizing the danger of late-stage diagnoses while highlighting new treatment and screening advances released for Prostate Cancer Awareness Month.

Baptist Health notes an increase in men being diagnosed at an advanced stage, while Loma Linda University provides guidance on avoiding late diagnoses. Publications such as Urology Times, Newswise, and Medscape Reference explore clinical guidelines and address medical facts regarding the condition. National and regional platforms including CTV News, WVTM, and WBNG feature survivor stories and expert advice from oncologists, such as guidance shared by a Bassett Health oncologist. The discussions coincide with the arrival of September, designated as Prostate Cancer Awareness Month, which serves as a seasonal focal point for public health campaigns. Commentary syndicated across outlets like the Saratogian, Findlay News, and the Daily Freeman urges men to break the silence surrounding the disease.

TODAY.com and health.com have published dedicated advisory pieces outlining specific questions men should ask physicians regarding personal risk factors and prevention methods. Coverage from Yahoo, KOMO, and GlobeNewswire underscores the health risks of waiting for symptoms to appear before seeking medical evaluation. Coverage does not yet specify long-term policy shifts or legislative measures resulting from these awareness campaigns, leaving the immediate trajectory focused on education and personal health action. Readers must look to upcoming announcements from medical institutions, urology associations, and public health departments to see whether increased awareness translates directly into higher screening volumes. Future reports will likely monitor whether the three percent annual case rise prompts new clinical guidelines or altered screening age recommendations.